help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on November 6, 2008, doi:10.1165/rcmb.2008-0217OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2008-0217OCv1
40/6/643    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shukla, M. N.
Right arrow Articles by Ray, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shukla, M. N.
Right arrow Articles by Ray, P.
American Journal of Respiratory Cell and Molecular Biology. Vol. 40, pp. 643-653, 2009
© 2009 American Thoracic Society
DOI: 10.1165/rcmb.2008-0217OC

Hepatocyte Growth Factor Inhibits Epithelial to Myofibroblast Transition in Lung Cells via Smad7

Manasi N. Shukla1,*, Jane L. Rose1,*, Rabindranath Ray1, Kira L. Lathrop2, Anuradha Ray1 and Prabir Ray1

1 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and 2 Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Correspondence and requests for reprints should be addressed to Prabir Ray, Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, 3459 Fifth Avenue, MUH A628 NW, Pittsburgh, PA 15213. E-mail: rayp{at}pitt.edu

Idiopathic pulmonary fibrosis is a lethal parenchymal lung disease characterized by denudation of the lung epithelium, fibroblast proliferation, and collagen deposition. Cellular changes underlying disease progression involve injury to alveolar epithelial cells, epithelial to mesenchymal transition, proliferation of {alpha}-smooth muscle actin ({alpha}-SMA)–expressing myofibroblasts and of fibroblasts resulting in enhanced deposition of extracellular matrix proteins. Hepatocyte growth factor (HGF) inhibits progression of bleomycin-induced pulmonary fibrosis in mice. The mechanism underlying the inhibitory effect of HGF was investigated in an in vitro model. We show that HGF markedly antagonizes basal and transforming growth factor (TGF)-β–induced expression of myofibroblast markers such as {alpha}-SMA, collagen type 1, and fibronectin in rat alveolar epithelial cells. HGF also inhibited TGF-β–induced {alpha}-SMA expression in primary murine alveolar epithelial cells. Since TGF-β is known to regulate {alpha}-SMA expression, the effect of HGF on components of TGF-β signaling was investigated. HGF induced expression of Smad7, an inhibitor of TGF-β signaling, in a mitogen-activated protein kinase–dependent manner. HGF also induced the nuclear export of Smad7 and Smad ubiquitin regulatory factor 1 (Smurf1) to the cytoplasm. HGF-dependent decrease in {alpha}-SMA was abolished with specific siRNAs targeted to Smad7. Thus, induction of Smad7 by HGF serves to limit acquisition of the myofibroblast phenotype in alveolar epithelial cells.

Key Words: EMT • HGF • Smad7


CLINICAL RELEVANCE

This study shows the ability of hepatocyte growth factor (HGF) to up-regulate Smad7 expression and function in epithelial cells, which antagonizes generation of the fibroblast phenotype. Thus, development of small molecules that can activate the HGF receptor to achieve the same results would be beneficial in the treatment of pulmonary fibrosis.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2009 American Thoracic Society.
  2nd Annual Dinner